Literature DB >> 4200089

Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4200089

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN： 0512-3054


× No keyword cloud information.
  43 in total

1.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.

Authors:  Naman K Shah; Gajender P S Dhillon; Adtiya P Dash; Usha Arora; Steven R Meshnick; Neena Valecha
Journal:  Lancet Infect Dis       Date:  2011-01       Impact factor: 25.071

4.  In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.

Authors:  Kasia Stepniewska; Walter R J Taylor; Mayfong Mayxay; Ric Price; Frank Smithuis; Jean-Paul Guthmann; Karen Barnes; Hla Yin Myint; Martin Adjuik; Piero Olliaro; Sasithon Pukrittayakamee; Sornchai Looareesuwan; Tran Tinh Hien; Jeremy Farrar; François Nosten; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Response to chloroquine treatment in children with or without gametocytes during uncomplicated Plasmodium falciparum malaria.

Authors:  A A Adedeji; B A Fateye; A O J Amoo; A Sowunmi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

6.  Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas.

Authors:  A A Adedeji; F A Fehintola; N O Olasupo; T Balogun; A Sowunmi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-12       Impact factor: 3.267

7.  Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.

Authors:  S Krudsood; K Chalermrut; C Pengruksa; S Srivilairit; U Silachamroon; S Treeprasertsuk; S Kano; G M Brittenham; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-06       Impact factor: 0.267

8.  Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.

Authors:  Henglin Yang; Yaming Yang; Pinfang Yang; Xingliang Li; Baihe Gao; Zhiyong Zhang; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2008-09-06       Impact factor: 3.112

9.  Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children.

Authors:  Akintunde Sowunmi; Elsie O Adewoye; Grace O Gbotsho; Christian T Happi; Abayomi Sijuade; Onikepe A Folarin; Titilope M Okuboyejo; Obaro S Michael
Journal:  Malar J       Date:  2010-02-15       Impact factor: 2.979

10.  Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.

Authors:  David J Bacon; Doug Tang; Carola Salas; Norma Roncal; Carmen Lucas; Lucia Gerena; Lorena Tapia; A Alejandro Llanos-Cuentas; Coralith Garcia; Lelv Solari; Dennis Kyle; Alan J Magill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.